市場調査レポート
商品コード
1439201
実験用遠心分離機の世界市場の評価:製品タイプ別、モデルタイプ別、ローター設計別、使用法別、用途別、最終用途別、地域別、機会、予測(2017年~2031年)Laboratory Centrifuges Market Assessment, By Product, By Model Type, By Rotor Design, By Intended Use, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
実験用遠心分離機の世界市場の評価:製品タイプ別、モデルタイプ別、ローター設計別、使用法別、用途別、最終用途別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年02月28日
発行: Market Xcel - Markets and Data
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
世界の実験用遠心分離機の市場規模は、2023年の17億2,000万米ドルから2031年に23億1,000万米ドルに達し、予測期間の2024年~2031年にCAGRで3.73%の成長が見込まれています。市場の成長は、慢性疾患や感染症の有病率の上昇、バイオテクノロジー産業の技術の進歩、医療費の増加、政府の取り組み、政策、プログラムなどの要因によってもたらされます。
製薬企業やバイオテクノロジー企業の増加、官民部門からの投資の増加、複数の既存企業のプレゼンス、既存の市場参入企業間の合併・買収、提携、製品の発売などの発展戦略が、世界的に実験用遠心分離機の需要を加速しています。
さらに、世界の実験用遠心分離機市場は、世界レベルでの感染症と慢性疾患の有病率の大幅な上昇により、力強い成長を示しています。高齢化の進行は複数の疾患に対する脆弱性につながり、それによって世界は糖尿病、がん、心血管疾患などのような慢性疾患や感染症の高い有病率の影響を受けています。実験用遠心分離機は、臨床診断の分野で重要な役割を果たしています。遠心分離機は、疾患の原因となる物質の存在の検出において非常に効率的なツールです。先進のツールや機器を備えた最新の先進の実験室の採用による医療施設の改善、細胞培養、臨床診断、標本調製、DNA/RNA抽出における実験用遠心分離機の利用の拡大などのその他の要因は、市場の成長をさらに加速させている要因です。
卓上遠心分離機のような高効率で可搬式かつコンパクトな実験用遠心分離機を開発するため、技術の進歩が急速に起こっています。バイオメディカルとバイオテクノロジーの進歩は、ライフサイエンス産業の著しい成長とともに、DNAシーケンシング、プロテオミクス、細胞培養などのさまざまな用途向けの実験用遠心分離機の需要を促進しています。
新興市場におけるバイオテクノロジー産業の発展に向けた助成金や基金といった政府の取り組みは、定期的なスクリーニングを推進しています。さらに、実験用遠心分離機の幅広い用途とライフサイエンス産業におけるその重要な役割により、多くの公開会社や非公開会社が技術革新、新発売、研究開発、より効率的で効果的な遠心分離機の開発に参加し投資しており、その結果、市場は驚異的な成長を示すと予測されます。
世界の疾病負担の増大
世界中での慢性疾患や感染症の増加により、実験用遠心分離機の需要が急増しています。医療診断は、医療産業における実験用遠心分離機のもっとも有用な用途の1つです。遠心分離機は、貧血のような状態を診断するための赤血球や酸素含有量、感染症の検出に用いる白血球、腎臓の健康状態を示す尿素やクレアチンのような一般的なバイオマーカーに用いる血漿など、血液標本のさまざまな要素を分離することによって疾患を診断するのに役立ちます。
さまざまな疾病に罹患する人が増加するにつれ、実験用遠心分離機の用途と需要は拡大しています。世界保健機関(WHO)によると、2022年に113万人のHIV陰性者が結核で死亡すると推定されています。World Heart Federationによれば、5億人以上が心血管疾患に罹患しており、2021年の死亡者数は2,050万人でした。心臓病は死因の第1位で、がん、脳卒中、呼吸器疾患、アルツハイマー病、糖尿病がこれに続きます。
大規模に成長するライフサイエンス産業
実験用遠心分離機は、研究や診断に不可欠なさまざまなプロセスを促進することで、ライフサイエンス産業において重要な役割を果たしています。その主な機能には、標本分離、細胞培養、臨床診断、創薬、ウイルス精製、品質管理などがあります。技術の進歩や、ゲノム、プロテオミクス、ハイスループットスクリーニングの研究開発を強化する政府資金の増加などのさまざまな要因により、ライフサイエンス産業は近年大幅な成長を示しています。医薬品やバイオテクノロジー製品、医療機器に対する需要の増加が、ライフサイエンス産業の成長と発展にさらに寄与しています。
当レポートでは、世界の実験用遠心分離機市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。
Global laboratory centrifuges market is projected to witness a CAGR of 3.73% during the forecast period 2024-2031, growing from USD 1.72 billion in 2023 to USD 2.31 billion in 2031. Growth in the global laboratory centrifuges market is driven by factors such as the rising prevalence of chronic and infectious diseases, technological advancements in the biotechnological industry, increased healthcare expenditure, government initiatives, policies, and programs.
Increasing number of pharmaceuticals and biotechnological companies, growing investments from private and public sector, presence of several established players and development strategies such as mergers and acquisitions, collaborations, and product launches amongst existing market players are accelerating the demand for laboratory centrifuges globally.
Furthermore, the global laboratory centrifuges market is undergoing robust growth due to a significant rise in the prevalence of infectious and chronic diseases at the global level. Increasing aging population leads to vulnerability towards several health conditions, due to which, the world is affected by high prevalence of chronic and infectious diseases such as diabetes, cancer, cardiovascular diseases and others. Laboratory centrifuges play a crucial role in the field of clinical diagnosis. It is a highly efficient tool in detecting the presence of disease-causing agents. Other factors such as improvement in healthcare facilities by adoption of latest advanced laboratories with advanced tools and equipment, growing application of laboratory centrifuges in cell culture, clinical diagnosis, sample preparation, DNA/RNA extraction are the factors which are further accelerating the growth in global laboratory centrifuges market.
Technological advancements are happening rapidly to develop highly efficient, portable, and compact laboratory centrifuges such as benchtop centrifuges. Biomedical and biotechnological advancements, along with the tremendous growth of the life science industry, are driving the demand for laboratory centrifuges for various applications such as DNA sequencing, proteomics, and cell culture.
Government initiatives such as grants and funds for the development of the biotechnological industry in emerging markets are encouraging regular screening. Moreover, the wide range of applications of laboratory centrifuges and their crucial role in the life science industry is attracting many public and private companies to join and invest in innovations, new launches, research, and development of more efficient and effective centrifuges development, due to which the market is expected to show tremendous growth.
Rise in Global Burden of Diseases
There has been a surge in demand for laboratory centrifuges due to the rising number of chronic and infectious diseases worldwide. Health diagnostics is one of the most useful applications of laboratory centrifuges in the healthcare industry. Centrifuges helps diagnose disease by separating different elements of blood samples, such as red blood cells and oxygen content, to diagnose conditions like anemia, white blood cells for detecting infections, and plasma for common biomarkers such as urea and creatine, which indicate kidney health.
As the number of people affected by several diseases increases, application and demand of laboratory centrifuges is growing. According to the World Health Organization (WHO), an estimated 1.13 million HIV-negative people died from tuberculosis (TB) in 2022. As per the World Heart Federation, more than half a billion people are affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021. Heart diseases are the leading cause of death, followed by cancer, stroke, respiratory diseases, Alzheimer's, and diabetes.
Life Sciences Industry Growing at a Massive Scale
Laboratory centrifuges play a crucial role in the life science industry by facilitating various processes essential for research and diagnosis. Their main functions include sample separation, cell culture, clinical diagnosis, drug discovery, virus purification, and quality control. The life science industry has experienced significant growth in recent years due to various factors such as technological advancements and increased government funds to enhance research and development in genomics, proteomics, and high-throughput screening. Increased demand for pharmaceutical and biotechnological products and medical devices has further contributed to the life sciences industry's growth and development.
According to an announcement by the Council of State Bioscience Association in June 2023, there has been a rapid demand for tools used in the life science industry in recent years. Innovation in the biotechnology sector, growth in research laboratories, increasing investments by public and private organizations, and funding from the government to accelerate research in all the life sciences sub-sectors are escalating growth in the industry. As the life science industry is growing, the demand for tools and appliances used in the industry such as laboratory centrifuges is increasing, and hence, the global laboratory centrifuges market is expected to show tremendous growth in the forecast period.
Microcentrifuges Dominate the Market
Among the product segments, microcentrifuges hold the maximum market share in the global laboratory centrifuges market. Growing research and development activities and investments by key market players in the segment are leading to massive demand for laboratory centrifuges. Moreover, these are useful for DNA/RNA extraction, protein purification, and sample preparation in molecular biology and biochemistry. Due to this, many key market players include microcentrifuges in their product portfolio.
In April 2023, Eppendorf SE announced the launch of "Centrifuge 5427 R", which is Eppendorf's first microcentrifuge with hydrocarbon cooling. The product uses a natural cooling agent with a low global warming potential (GWP) that makes it a sustainable product and has large rotor selection, along with high sample throughput, which enables the user to perform various molecular and cell biology applications. Technological advancement in microcentrifuges and supportive regulatory system is enabling the manufacturers of laboratory centrifuges to invest and bring innovative products, driving the global laboratory centrifuges market.
Increasing Demand for Benchtop Centrifuges
Among the model type category, benchtop centrifuges hold a significant market share in global laboratory centrifuges. Benchtop centrifuges are compact, tabletop-sized centrifuges used in laboratories for small to medium-scale sample processing. Due to their compact design, these are suitable for laboratories with limited space. These are used in various applications such as sample preparation, cell culture, clinical diagnosis, and other routine laboratory tasks, which makes them more popular among manufacturers. Moreover, key market players are bringing new product launches into the segment by developing advanced benchtop centrifuges.
In February 2022, Beckman Coulter Life Sciences, a global organization working on manufacturing medical products, launched its most versatile 3-liter benchtop centrifuge known as "the Allegra V-15R refrigerated centrifuge". The newest product, which supports many workflows and applications like cell and blood separation with high-throughput screening, comprises 10 rotor configurations, 50 programmable runs, and a comprehensive array of adapters.
Asia-Pacific is Expected to be the Fastest Growing Region
The rapidly increasing population and growing prevalence of chronic and infectious diseases in the region are expected to accelerate the demand for highly efficient laboratory centrifuges in the healthcare sector to improve clinical diagnosis and enhance clinical decision-making. Asia-Pacific is an emerging market with huge potential for laboratory centrifuge application in all sectors, due to which key market players are establishing manufacturing and operational facilities in the region to expand their business and overall market growth.
Biotechnology Industry Research Assistance Council (BIRAC) launched a scheme known as the Biotechnology Ignition Grant Scheme (BIG), under which successful innovators will receive up to USD 70,000 for research projects related to biomedical devices such as centrifuges, biotechnological products, biosimilars, stem cells, and other biotechnological products development. These initiatives draw major investments from foreign companies into countries like Taiwan, China, Malaysia, and India, which have developed medical device industries, advanced manufacturing facilities, and a large pool of suppliers ready to provide high-quality goods at competitive prices to customers globally.
Future Market Scenario (2024 - 2031F)
The increasing prevalence of chronic and infectious diseases worldwide has increased the demand for laboratory centrifuges in the clinical diagnostics field. The growing life science industry and increased demand for advanced laboratory centrifuges for a wide range of applications in the biotechnological sector will further accelerate the growth of the market.
Increasing healthcare budgets of governments, increasing investments by government bodies in research and development, technological advancements, and the development of compact and sustainable products are driving the demand for laboratory centrifuges globally. Moreover, collaborative ventures involving manufacturers of medical devices and biotechnological companies have spurred innovation and growth in the global laboratory centrifuges market.
Key Players Landscape and Outlook
In the global laboratory centrifuges market, public and private organizations from various domains of the life sciences industry are establishing strategic partnerships and distribution agreements, which play a pivotal role in propelling the global laboratory centrifuges market's expansion. These alliances empower firms to gain from each other's strengths, benefit from access to new markets and technologies, and pool resources for research and development endeavors. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative initiatives promote innovation, expedite product development, and improve disease treatment. In January 2023, Hettich Group, a global leader specializing in centrifuges and incubators for clinical-medical applications, announced that it completed the acquisition of Philipp Kirsch GmbH. The acquisition aimed to improve and expand the company's existing centrifuges product portfolio.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.